reference/20930804

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20930804

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	418
issn	1476-4687 0028-0836
issueIdentifier	7664
pageRange	413-418
publicationName	Nature
startingPage	413
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8d193481882a5dd016cb4f3ed9334aa0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_644807547fa9bc0d688cafc37f459a8b
bibliographicCitation	Manguso RT, Pope HW, Zimmer MD, Brown FD, Yates KB, Miller BC, Collins NB, Bi K, LaFleur MW, Juneja VR, Weiss SA, Lo J, Fisher DE, Miao D, Van Allen E, Root DE, Sharpe AH, Doench JG, Haining WN. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target. Nature. 2017 Jul 27;547(7664):413–8. PMID: 28723893; PMCID: PMC5924693.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0cb5feb891e7d8627e0e214e135156b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54a715de315780fa4f4d65816ea0f2e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0850ca2bc5fa214cb52998558a359297 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51ae39d4464719b81d56d768fac02339 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_959db9ea34321a12d8cd3409946ce33d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_247ee6d982995e4fd184fc4a5eb8ccc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a8481383cfce29870da61405eb5c1f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_758b80714c086b55289caf99f9bb55e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcd0261702ed160945951ea4db8d81bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ce1d12873b4826ffbddeea7237f5a54 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b83ce2a8dfb77388a2d618600d7bdc0b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30ff4b2085aece9af2c345d4f72d4a8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ff8142b20ef7f07ba0ac7c93e12dce1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f8a6c0a94ffbb170560f31cc3b77dbe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14815192a5f282d75f39404344461cfc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a1f0d0086e487e186899b9d84120ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8735a0d11270595ee0653ed4366d5ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_28952e187b20765dbb1da88949ff02c0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_725eada881dc99d60174da8d91dac48a
date	2017-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/28723893 https://doi.org/10.1038/nature23270 https://pubmed.ncbi.nlm.nih.gov/PMC5924693
isPartOf	https://portal.issn.org/resource/ISSN/1476-4687 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6011 https://portal.issn.org/resource/ISSN/0028-0836
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
discusses	http://id.nlm.nih.gov/mesh/M0024955 http://id.nlm.nih.gov/mesh/M0011491 http://id.nlm.nih.gov/mesh/M0505977 http://id.nlm.nih.gov/mesh/M0228158
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0907de42401b965fd4aefb807d0b2038 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8680272a091c92d3238af542c3dc2155 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7a0153350cba31da4ce6bfa8f8c68f72 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b83d04d3e3b05ce10d1a5893dc850a9b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eaa50cf39d2760cde308f600aea8ec0e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/conserveddomain/PSSMID350455 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19255 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15979 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID20846

Total number of triples: 64.